These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 21604269)

  • 21. Parathyroid hormone: a double-edged sword for bone metabolism.
    Qin L; Raggatt LJ; Partridge NC
    Trends Endocrinol Metab; 2004 Mar; 15(2):60-5. PubMed ID: 15036251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The calcium-sensing receptor mediates bone turnover induced by dietary calcium and parathyroid hormone in neonates.
    Shu L; Ji J; Zhu Q; Cao G; Karaplis A; Pollak MR; Brown E; Goltzman D; Miao D
    J Bone Miner Res; 2011 May; 26(5):1057-71. PubMed ID: 21542007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A novel flavonoid C-glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone.
    Khan MP; Mishra JS; Sharan K; Yadav M; Singh AK; Srivastava A; Kumar S; Bhaduaria S; Maurya R; Sanyal S; Chattopadhyay N
    Phytomedicine; 2013 Nov; 20(14):1256-66. PubMed ID: 23928508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intermittent PTH administration improves alveolar bone formation in type 1 diabetic rats with periodontitis.
    Kim JH; Kim AR; Choi YH; Kim A; Sohn Y; Woo GH; Cha JH; Bak EJ; Yoo YJ
    J Transl Med; 2018 Mar; 16(1):70. PubMed ID: 29544500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibroblast Growth Factor Receptor 3 Deficiency Does Not Impair the Osteoanabolic Action of Parathyroid Hormone on Mice.
    Xie Y; Yi L; Weng T; Huang J; Luo F; Jiang W; Xian CJ; Du X; Chen L
    Int J Biol Sci; 2016; 12(8):990-9. PubMed ID: 27489502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of cyclic vs. daily treatment with human parathyroid hormone (1-34) on murine bone structure and cellular activity.
    Iida-Klein A; Lu SS; Cosman F; Lindsay R; Dempster DW
    Bone; 2007 Feb; 40(2):391-8. PubMed ID: 17056311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intermittent parathyroid hormone administration counteracts the adverse effects of glucocorticoids on osteoblast and osteocyte viability, bone formation, and strength in mice.
    Weinstein RS; Jilka RL; Almeida M; Roberson PK; Manolagas SC
    Endocrinology; 2010 Jun; 151(6):2641-9. PubMed ID: 20410195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mitogen-activated protein kinase phosphatase 1 regulates bone mass, osteoblast gene expression, and responsiveness to parathyroid hormone.
    Mahalingam CD; Datta T; Patil RV; Kreider J; Bonfil RD; Kirkwood KL; Goldstein SA; Abou-Samra AB; Datta NS
    J Endocrinol; 2011 Nov; 211(2):145-56. PubMed ID: 21852324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parathyroid hormone--a drug for orthopedic surgery?
    Skripitz R; Aspenberg P
    Acta Orthop Scand; 2004 Dec; 75(6):654-62. PubMed ID: 15762254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of angiotensin-converting enzyme inhibitor, captopril, on bone of mice with streptozotocin-induced type 1 diabetes.
    Diao TY; Pan H; Gu SS; Chen X; Zhang FY; Wong MS; Zhang Y
    J Bone Miner Metab; 2014 May; 32(3):261-70. PubMed ID: 23934056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rapamycin impairs trabecular bone acquisition from high-dose but not low-dose intermittent parathyroid hormone treatment.
    Niziolek PJ; Murthy S; Ellis SN; Sukhija KB; Hornberger TA; Turner CH; Robling AG
    J Cell Physiol; 2009 Dec; 221(3):579-85. PubMed ID: 19639601
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progenitor recruitment and adipogenic lipolysis contribute to the anabolic actions of parathyroid hormone on the skeleton.
    Maridas DE; Rendina-Ruedy E; Helderman RC; DeMambro VE; Brooks D; Guntur AR; Lanske B; Bouxsein ML; Rosen CJ
    FASEB J; 2019 Feb; 33(2):2885-2898. PubMed ID: 30354669
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Propranolol Promotes Bone Formation and Limits Resorption Through Novel Mechanisms During Anabolic Parathyroid Hormone Treatment in Female C57BL/6J Mice.
    Treyball A; Bergeron AC; Brooks DJ; Langlais AL; Hashmi H; Nagano K; Barlow D; Neilson RJ; Roy TA; Nevola KT; Houseknecht KL; Baron R; Bouxsein ML; Guntur AR; Motyl KJ
    J Bone Miner Res; 2022 May; 37(5):954-971. PubMed ID: 35122666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impaired bone anabolic effect of PTH in the absence of endogenous FGF2 is partially due to reduced ATF4 expression.
    Fei Y; Xiao L; Hurley MM
    Biochem Biophys Res Commun; 2011 Aug; 412(1):160-4. PubMed ID: 21806973
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The anabolic response to parathyroid hormone is augmented in Rac2 knockout mice.
    Kawano T; Troiano N; Adams DJ; Wu JJ; Sun BH; Insogna K
    Endocrinology; 2008 Aug; 149(8):4009-15. PubMed ID: 18467443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low-magnitude whole-body vibration does not enhance the anabolic skeletal effects of intermittent PTH in adult mice.
    Lynch MA; Brodt MD; Stephens AL; Civitelli R; Silva MJ
    J Orthop Res; 2011 Apr; 29(4):465-72. PubMed ID: 21337386
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anabolic effects of intermittent PTH on osteoblasts.
    Greenfield EM
    Curr Mol Pharmacol; 2012 Jun; 5(2):127-34. PubMed ID: 21787293
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The roles of parathyroid hormone in bone remodeling: prospects for novel therapeutics.
    Lombardi G; Di Somma C; Rubino M; Faggiano A; Vuolo L; Guerra E; Contaldi P; Savastano S; Colao A
    J Endocrinol Invest; 2011 Jul; 34(7 Suppl):18-22. PubMed ID: 21985975
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improving Combination Osteoporosis Therapy in a Preclinical Model of Heightened Osteoanabolism.
    Shao Y; Hernandez-Buquer S; Childress P; Stayrook KR; Alvarez MB; Davis H; Plotkin LI; He Y; Condon KW; Burr DB; Warden SJ; Robling AG; Yang FC; Wek RC; Allen MR; Bidwell JP
    Endocrinology; 2017 Sep; 158(9):2722-2740. PubMed ID: 28637206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endogenous parathyroid hormone-related protein compensates for the absence of parathyroid hormone in promoting bone accrual in vivo in a model of bone marrow ablation.
    Zhu Q; Zhou X; Zhu M; Wang Q; Goltzman D; Karaplis A; Miao D
    J Bone Miner Res; 2013 Sep; 28(9):1898-911. PubMed ID: 23716486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.